Neurocrine Biosciences Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$805,500	$794,900	$687,500	$572,600
Gross Profit	787,900	780,900	676,200	563,400
EBITDA	235,400	299,500	152,900	31,300
EBIT	227,900	291,800	145,600	23,700
Net Income	153,700	209,500	107,500	7,900
Net Change In Cash	805,500	794,900	687,500	572,600
Free Cash Flow	390,800	214,300	89,500	54,100
Cash	713,000	340,200	264,000	194,100
Basic Shares	102,500	102,500	101,000	102,500

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$2,860,500	$2,355,300	$1,887,100	$1,488,700
Gross Profit	2,808,400	2,321,300	1,847,400	1,465,500
EBITDA	666,600	639,700	416,100	264,600
EBIT	636,500	612,600	394,800	249,000
Net Income	478,600	341,300	249,700	154,500
Net Change In Cash	2,860,500	2,355,300	1,887,100	1,488,700
Cost of Revenue				-72,000
Free Cash Flow	748,700	557,200	361,600	322,900
Cash	713,000	233,000	251,100	262,900
Basic Shares	102,500	103,700	101,000	98,900